ecancer

Education and training in the EurocanPlatform project

Dr Angelo Paradiso - National Cancer Research Institute, Bari, Italy

4 Dec 2015

Highlights of the EurocanPlatform Project

2 Dec 2015

Highlights of Cancer Prevention Europe

Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France

2 Dec 2015

Cancer Core Europe: what has been achieved one year on?

Prof Alexander Eggermont and Prof Julio Celis

2 Dec 2015

Cancer Prevention Europe

Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France

2 Dec 2015

Cancer Core Europe: one year on (full version)

Prof Alexander Eggermont - Gustave Roussy, Villejuf, France

2 Dec 2015

What is the relationship between PD-L1 expression and antitumour activity?

Dr Paolo Ascierto - National Tumor Institute, Naples, Italy

19 Nov 2015

Prognostic value of BRAFV600 mutations in stage 3 cutaneous melanoma patients

Prof Philippe Saiag - University of Versailles, Versailles, France

5 Nov 2015

What are the prognostic values of 25-hydroxyvitamin D3 levels at diagnosis and follow-up?

Prof Philippe Saiag - University of Versailles, Versailles, France

5 Nov 2015

Anti-PD1 or tyrosine kinase inhibitors?

Dr Mark Middleton - University of Oxford, Oxford, UK

5 Nov 2015

New drugs and new trials in melanoma

Prof Jean-Jacques Grob - Marseille University, Marseille, France

5 Nov 2015

Highlights of EADO 2015

Prof Jean-Jacques Grob - Marseille University, Marseille, France

5 Nov 2015

More from ecancer